Chengdu Kanghong Pharmaceutical Group Co., Ltd.
Chengdu Kanghong Pharmaceutical Group is a listed Chinese pharmaceutical company engaged in the research, development, manufacture and sale of medicines. Its business includes biologic therapies, conventional small-molecule pharmaceutical products and traditional Chinese medicine activities. The company conducts innovative therapeutic research in ophthalmology, neurology and selected oncology areas while also operating established commercial medicine businesses. Kanghong is headquartered in Chengdu, Sichuan, and trades on the Shenzhen Stock Exchange under code 002773. Product-specific claims, regulatory changes and scientific updates are maintained through official company and exchange announcements.
Company at a glance
Corporate information
- Company entity
- Chengdu Kanghong Pharmaceutical Group Co., Ltd.
- Headquarters / principal office
- China
- Founded
- Not verified
- Ownership / capital status
- Publicly tradedPublicly listed
- Official corporate reference
- https://www.cnkh.com/
- LinkedIn company page
- Independent company page not verified
Profile review: 2026-11-08 · Fields retain their individual source dates. Undisclosed values are not zero; early or historical events do not establish the latest financing. Awards and acquisitions are distinguished from equity rounds.
Listed issuer and R&D focus
SZSE: 002773
biologics · small molecules · traditional Chinese medicines
ophthalmology · central nervous system · oncology
Last independently verified:
Disease tags match recorded text mentions and require program-level verification.
Technology, programs & evidence
Chengdu Kanghong Pharmaceutical Group is a listed Chinese pharmaceutical company engaged in the research, development, manufacture and sale of medicines. Its business includes biologic therapies, conventional small-molecule pharmaceutical products and traditional Chinese medicine activities. The company conducts innovative therapeutic research in ophthalmology, neurology and selected oncology areas while also operating established commercial medicine businesses. Kanghong is headquartered in Chengdu, Sichuan, and trades on the Shenzhen Stock Exchange under code 002773. Product-specific claims, regulatory changes and scientific updates are maintained through official company and exchange announcements.
Business, technology & evidence
- SecuritiesSZSE: 002773
Individual program detail is not recorded. Consult the original sources below.
Related news & literature
Company-name matches are discovery leads; verify entity identity and transaction roles in the original source.
Showing 0 / 0 related items
No cataloged update explicitly mentions this company.
Same-field reading (not company-specific)
Research this company together
Discussions are for signed-in members. Personal notes remain separate from company research.
Sign in to joinSources & open questions
- Official issuer and R&D disclosure · Chengdu Kanghong Pharmaceutical Group Co., Ltd. ↗Chengdu Kanghong Pharmaceutical Group Co., Ltd. ·
- Official issuer and R&D disclosure · Chengdu Kanghong Pharmaceutical Group Co., Ltd. ↗Chengdu Kanghong Pharmaceutical Group Co., Ltd. ·
Inclusion is not endorsement or partner qualification. Assess company claims, clinical evidence, and project-specific capabilities separately.